Physician
Gulf Coast Pathology Associates PLLC
Gulf Coast Pathology Associates PLLC was paid $2.11M by Medicaid between Nov 2020 and Nov 2024, across 100 billing codes. Its largest line is 81408, — 18% of everything it billed.
33Billing provider infoGULF COAST PATHOLOGY ASSOCIATES PLLC
HOUSTON, TX 77054
HOUSTON, TX 77054
33aNPI1336100858assigned 04/01/2006
33bProvider typeBlood Banking & Transfusion Medicine Physician
28Total paid$2.11M
24GClaims153,766
24DCodes billed100
24AFirst – last monthNov 2020 – Nov 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 81 | $4K | |
| 2021 | 451 | $15K | |
| 2022 | 80,273 | $474K | |
| 2023 | 50,538 | $1.04M | |
| 2024incomplete | 22,423 | $579K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 81408 | 18% | 662 | 349 | $390K | |
| 81420 | Fetal chromosomal aneuploidy genomic sequence analysis panel | 18% | 952 | 883 | $377K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 7.6% | 11,195 | 2,537 | $160K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 6.5% | 9,898 | 9,429 | $138K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 6.5% | 9,882 | 9,416 | $137K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 5.0% | 7,405 | 6,981 | $106K |
| 87481 | 4.6% | 8,597 | 4,154 | $98K | |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | 4.2% | 453 | 438 | $89K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 2.9% | 5,628 | 5,396 | $61K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 2.8% | 7,649 | 7,290 | $60K |
| 87511 | 2.3% | 4,446 | 4,183 | $48K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 2.0% | 3,024 | 2,887 | $42K |
88 more codes
| 81406 | 1.5% | 358 | $33K | |
| 81401 | 1.3% | 658 | $27K | |
| 86780 | <1% | 3,953 | $18K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 7,531 | $17K |
| 86762 | <1% | 3,389 | $16K | |
| 82105 | <1% | 2,610 | $16K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 5,340 | $16K |
| 86803 | <1% | 3,442 | $15K | |
| 81161 | <1% | 357 | $15K | |
| 87340 | <1% | 4,086 | $14K | |
| 81400 | <1% | 661 | $14K | |
| 81404 | <1% | 255 | $12K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 397 | $12K |
| 86850 | <1% | 3,569 | $12K | |
| 87081 | <1% | 5,163 | $11K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,946 | $10K |
| 81405 | <1% | 131 | $10K | |
| 86787 | <1% | 2,169 | $9K | |
| 88307 | <1% | 127 | $7K | |
| 80081 | <1% | 391 | $7K | |
| 81257 | <1% | 353 | $6K | |
| 84702 | <1% | 1,249 | $6K | |
| 85027 | <1% | 1,934 | $5K | |
| 86592 | <1% | 3,869 | $5K | |
| 82950 | <1% | 3,480 | $5K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,339 | $4K |
| 82951 | <1% | 1,134 | $4K | |
| 80053 | Comprehensive metabolic panel | <1% | 1,329 | $4K |
| 87186 | <1% | 1,238 | $4K | |
| 81361 | <1% | 126 | $4K | |
| 86900 | <1% | 3,546 | $3K | |
| 86901 | <1% | 3,547 | $3K | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 79 | $3K |
| 81243 | <1% | 373 | $3K | |
| 81255 | <1% | 337 | $3K | |
| 81200 | <1% | 337 | $3K | |
| 82570 | <1% | 2,006 | $3K | |
| 86696 | <1% | 357 | $2K | |
| 81329 | <1% | 33 | $2K | |
| 81260 | <1% | 337 | $2K | |
| 84144 | <1% | 332 | $2K | |
| 87077 | <1% | 854 | $2K | |
| 83001 | <1% | 308 | $2K | |
| 82947 | <1% | 1,923 | $2K | |
| 87653 | <1% | 236 | $2K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 316 | $2K |
| 88141 | <1% | 274 | $2K | |
| 84146 | <1% | 225 | $2K | |
| 81250 | <1% | 196 | $2K | |
| 81251 | <1% | 337 | $2K | |
| 84439 | <1% | 555 | $1K | |
| 88342 | <1% | 66 | $1K | |
| 81330 | <1% | 196 | $1K | |
| 81290 | <1% | 196 | $1K | |
| 82952 | <1% | 1,074 | $1K | |
| 81209 | <1% | 196 | $1K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 79 | $1K |
| 81242 | <1% | 195 | $1K | |
| 83002 | <1% | 128 | $1K | |
| 80061 | Lipid panel | <1% | 291 | $987.38 |
| 82670 | <1% | 66 | $816.77 | |
| 86695 | <1% | 139 | $813.87 | |
| 81001 | <1% | 606 | $711.16 | |
| 84403 | <1% | 95 | $703.56 | |
| 82728 | <1% | 80 | $629.75 | |
| 83020 | <1% | 126 | $582.66 | |
| 82239 | <1% | 110 | $554.00 | |
| 84481 | <1% | 161 | $488.36 | |
| 87625 | <1% | 287 | $367.86 | |
| 87529 | <1% | 26 | $344.94 | |
| 84402 | <1% | 14 | $256.68 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 14 | $240.00 |
| 88312 | <1% | 16 | $216.37 | |
| 87341 | <1% | 39 | $188.05 | |
| 84156 | <1% | 116 | $96.62 | |
| 82627 | <1% | 17 | $89.63 | |
| 81003 | <1% | 51 | $69.84 | |
| 86705 | <1% | 64 | $39.56 | |
| 86709 | <1% | 49 | $37.84 | |
| 86694 | <1% | 13 | $35.67 | |
| 84270 | <1% | 29 | $34.68 | |
| 84550 | <1% | 53 | $34.01 | |
| 85018 | <1% | 32 | $33.73 | |
| 80076 | <1% | 14 | $27.10 | |
| 86593 | <1% | 19 | $25.36 | |
| 85660 | <1% | 31 | $23.15 | |
| 83655 | <1% | 16 | $9.66 | |
| 81422 | 0% | 179 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialOLIVER, BRIAN (CFO)
| Provider | Location | Paid |
|---|---|---|
| Arbor Diagnostics INC | Dallas, TX | $1.59M |
| Northern Michigan Chiropractic Center, PLC | Gaylord, MI | $94K |
| MPL INC | Longview, TX | $43K |
| Med Path Labs INC | Longview, TX | $1K |
| Gulf Coast Pathology Associates PLLC | Houston, TX | $937.71 |
| Arbor Diagnostics INC | Dallas, TX | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.